{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:47:23Z","timestamp":1789379243540,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T00:00:00Z","timestamp":1348790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00134-012-2688-8","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T05:07:26Z","timestamp":1348808846000},"page":"1990-1998","source":"Crossref","is-referenced-by-count":73,"title":["Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness"],"prefix":"10.1007","volume":"38","author":[{"given":"J.-C.","family":"Devaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pannatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Marques-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tappy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chiolero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Voirol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,28]]},"reference":[{"key":"2688_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00003246-199701000-00009","volume":"25","author":"R Barrientos-Vega","year":"1997","unstructured":"Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A (1997) Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 25:33\u201340","journal-title":"Crit Care Med"},{"key":"2688_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccc.2005.08.008","volume":"22","author":"PE Marik","year":"2006","unstructured":"Marik PE (2006) Dyslipidemia in the critically ill. Crit Care Clin 22:151\u2013159 viii","journal-title":"Crit Care Clin"},{"key":"2688_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00002018-200124060-00003","volume":"24","author":"AK Mantel-Teeuwisse","year":"2001","unstructured":"Mantel-Teeuwisse AK, Kloosterman JME, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A (2001) Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf 24:443\u2013456","journal-title":"Drug Saf"},{"key":"2688_CR4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.reaurg.2005.04.002","volume":"14","author":"V Maxime","year":"2005","unstructured":"Maxime V, Annane D (2005) Manifestations endocriniennes li\u00e9es au sepsis. R\u00e9animation 14:230\u2013237","journal-title":"R\u00e9animation"},{"key":"2688_CR5","first-page":"46","volume":"1","author":"Y B\u00e9zie","year":"2003","unstructured":"B\u00e9zie Y, Cattan V, Fractal LP, Lescol LP (2003) Comparaison des diff\u00e9rentes statines: implications cliniques et choix th\u00e9rapeutiques. MT Cardio 1:46\u201354","journal-title":"MT Cardio"},{"key":"2688_CR6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0899-9007(00)00381-6","volume":"16","author":"MA Crook","year":"2000","unstructured":"Crook MA (2000) Lipid clearance and total parenteral nutrition: the importance of monitoring plasma lipids. Nutrition 16:774\u2013775","journal-title":"Nutrition"},{"key":"2688_CR7","first-page":"130","volume":"13","author":"MR Shams","year":"2009","unstructured":"Shams MR, Tavassoli N, Plicaud H, Genestal M (2009) Incidence and risk factors of hypertriglyceridemia in the ICU. Crit Care Med 13:130","journal-title":"Crit Care Med"},{"key":"2688_CR8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0261-5614(03)00082-7","volume":"22","author":"J Llop","year":"2003","unstructured":"Llop J, Sabin P, Garau M, Burgos R, Perez M, Masso J, Cardona D, Sanchez Segura JM, Garriga R, Redondo S, Sagales M, Ferrer D, Pons M, Vuelta M, Fabregas X, Vitales M, Casasin T, Martinez J, Morato L, Soler M (2003) The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr 22:577\u2013583","journal-title":"Clin Nutr"},{"key":"2688_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2261-8-6","volume":"8","author":"M Firmann","year":"2008","unstructured":"Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8:6","journal-title":"BMC Cardiovasc Disord"},{"key":"2688_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jc.2003-030760","volume":"89","author":"D Mesotten","year":"2004","unstructured":"Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metabol 89:219\u2013226","journal-title":"J Clin Endocrinol Metabol"},{"key":"2688_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nupar.2007.01.011","volume":"21","author":"B Verg\u00e8s","year":"2007","unstructured":"Verg\u00e8s B (2007) Physiopathologie de la dyslipid\u00e9mie du syndrome m\u00e9tabolique et du diab\u00e8te de type 2. Nut Clin Metabol 21:9\u201316","journal-title":"Nut Clin Metabol"},{"key":"2688_CR12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","volume":"33","author":"JY Chien","year":"2005","unstructured":"Chien JY, Jerng JS, Yu CJ, Yang PC (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33:1688","journal-title":"Crit Care Med"},{"key":"2688_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clnu.2009.04.024","volume":"28","author":"P Singer","year":"2009","unstructured":"Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN (2009) ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 28:387\u2013400","journal-title":"Clin Nutr"},{"key":"2688_CR14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/ajcn\/61.4.812","volume":"61","author":"W Druml","year":"1995","unstructured":"Druml W, Fischer M, Pidlich J, Lenz K (1995) Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr 61:812\u2013817","journal-title":"Am J Clin Nutr"},{"key":"2688_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5551\/jat.10.321","volume":"10","author":"S Tanaka","year":"2003","unstructured":"Tanaka S, Miki T, Hsieh ST, Kim JI, Yasumoto T, Taniguchi T, Ishikawa Y, Yokoyama M (2003) A case of severe hyperlipidemia caused by long-term tube feedings. J Atheroscler Thromb 10:321\u2013324","journal-title":"J Atheroscler Thromb"},{"key":"2688_CR16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1213\/00000539-200210000-00024","volume":"95","author":"HJ Theilen","year":"2002","unstructured":"Theilen HJ, Adam S, Albrecht MD, Ragaller M (2002) Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 95:923\u2013929 (table of contents)","journal-title":"Anesth Analg"},{"key":"2688_CR17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.clinbiochem.2008.04.004","volume":"41","author":"NB Al Riyami","year":"2008","unstructured":"Al Riyami NB, Frohlich J (2008) Extreme hypertriglyceridemia following intravenous heparin infusion. Clin Biochem 41:907\u2013909","journal-title":"Clin Biochem"},{"key":"2688_CR18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mlc.2001.117666","volume":"138","author":"B Nasstrom","year":"2001","unstructured":"Nasstrom B, Olivecrona G, Olivecrona T, Stegmayr BG (2001) Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med 138:206\u2013213","journal-title":"J Lab Clin Med"},{"key":"2688_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-2-287-33475-7_13","volume-title":"Aspects m\u00e9taboliques et nutritionnels des cat\u00e9cholamines et des glucocortio\u00efdesTrait\u00e9 de nutrition artificielle de l\u2019adulte","author":"YA Que","year":"2007","unstructured":"Que YA, Bracco D, Chiol\u00e9ro RL (2007) Aspects m\u00e9taboliques et nutritionnels des cat\u00e9cholamines et des glucocortio\u00efdesTrait\u00e9 de nutrition artificielle de l\u2019adulte. Springer, Berlin, pp 183\u2013191"},{"key":"2688_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0735-1097(02)02848-6","volume":"41","author":"RJ Gibbons","year":"2003","unstructured":"Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM (2003) ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina\u2014summary article: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41:159","journal-title":"J Am Coll Cardiol"},{"key":"2688_CR21","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","volume":"33","author":"T Calandra","year":"2005","unstructured":"Calandra T, Cohen J (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538","journal-title":"Crit Care Med"},{"key":"2688_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nut.2005.04.017","volume":"22","author":"MM Berger","year":"2006","unstructured":"Berger MM, Revelly JP, Wasserfallen JB, Schmid A, Bouvry S, Cayeux MC, Musset M, Maravic P, Chiolero RL (2006) Impact of a computerized information system on quality of nutritional support in the ICU. Nutrition 22:221\u2013229","journal-title":"Nutrition"},{"key":"2688_CR23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/CCM.0b013e31822f0ad7","volume":"40","author":"L Soguel","year":"2012","unstructured":"Soguel L, Revelly JP, Schaller MD, Longchamp C, Berger MM (2012) Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: The intensive care unit dietitian can make the difference. Crit Care Med 40:412","journal-title":"Crit Care Med"},{"key":"2688_CR24","doi-asserted-by":"crossref","DOI":"10.1002\/9780470773666","volume-title":"Statistical methods in medical research","author":"P Armitage","year":"2002","unstructured":"Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research. Wiley, London"},{"key":"2688_CR25","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/00003246-199712000-00012","volume":"25","author":"G McLeod","year":"1997","unstructured":"McLeod G, Dick J, Wallis C, Patterson A, Cox C, Colvin J (1997) Propofol 2\u00a0% in critically ill patients: effect on lipids. Crit Care Med 25:1976\u20131981","journal-title":"Crit Care Med"},{"key":"2688_CR26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000542-200510000-00026","volume":"103","author":"MT Baker","year":"2005","unstructured":"Baker MT, Naguib M (2005) Propofol: the challenges of formulation. Anesthesiology 103:860\u2013876","journal-title":"Anesthesiology"},{"key":"2688_CR27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1186\/cc8177","volume":"13","author":"OL Cremer","year":"2009","unstructured":"Cremer OL (2009) The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder. Crit Care 13:1012","journal-title":"Crit Care"},{"key":"2688_CR28","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1097\/CCM.0b013e3181de125a","volume":"38","author":"JW Devlin","year":"2010","unstructured":"Devlin JW, Mallow-Corbett S, Riker RR (2010) Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 38:S231","journal-title":"Crit Care Med"},{"key":"2688_CR29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","volume":"29","author":"B Vasile","year":"2003","unstructured":"Vasile B, Rasulo F, Candiani A, Latronico N (2003) The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29:1417\u20131425","journal-title":"Intensive Care Med"},{"key":"2688_CR30","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1592\/phco.2005.25.10.1348","volume":"25","author":"JW Devlin","year":"2005","unstructured":"Devlin JW, Lau AK, Tanios MA (2005) Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy 25:1348\u20131352","journal-title":"Pharmacotherapy"},{"key":"2688_CR31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajhp\/54.6.694","volume":"54","author":"MS Roth","year":"1997","unstructured":"Roth MS, Martin AB, Katz JA (1997) Nutritional implications of prolonged propofol use. Am J Health Syst Pharm (AJHP) 54:694","journal-title":"Am J Health Syst Pharm (AJHP)"},{"key":"2688_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nupar.2007.01.007","volume":"21","author":"V Petit","year":"2007","unstructured":"Petit V, Niot I, Poirier H, Besnard P (2007) Absorption intestinale des acides gras: faits et incertitudes. Nut Clin Metabol 21:38\u201345","journal-title":"Nut Clin Metabol"},{"key":"2688_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nupar.2006.04.001","volume":"20","author":"C Chambrier","year":"2006","unstructured":"Chambrier C, Lauverjat M, Bouletreau P (2006) Emulsions lipidiques: indication des diff\u00e9rentes \u00e9mulsions lipidiques. Nut Clin Metabol 20:73\u201378","journal-title":"Nut Clin Metabol"},{"key":"2688_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00000658-198208000-00016","volume":"196","author":"J Nordenstrom","year":"1982","unstructured":"Nordenstrom J, Carpentier YA, Askanazi J, Robin AP, Elwyn DH, Hensle TW, Kinney JM (1982) Metabolic utilization of intravenous fat emulsion during total parenteral nutrition. Ann Surg 196:221\u2013231","journal-title":"Ann Surg"},{"key":"2688_CR35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.clnu.2006.03.008","volume":"25","author":"L Tappy","year":"2006","unstructured":"Tappy L, Berger MM, Schwarz JM, Schneiter P, Kim S, Revelly JP, Chiolero R (2006) Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 25:588\u2013595","journal-title":"Clin Nutr"},{"key":"2688_CR36","doi-asserted-by":"crossref","first-page":"361.e7","DOI":"10.1016\/j.jcrc.2009.08.006","volume":"25","author":"C Chiarla","year":"2010","unstructured":"Chiarla C, Giovannini I, Giuliante F, Zadak Z, Vellone M, Ardito F, Clemente G, Murazio M, Nuzzo G (2010) Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care 25:361.e7\u2013361.e12","journal-title":"J Crit Care"},{"key":"2688_CR37","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/cc11418","volume":"16","author":"A Nielsen","year":"2012","unstructured":"Nielsen A, Nielsen R, Riis A, Johnsen S, Sorensen H, Thomsen R (2012) The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study. Crit Care 16:R122","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-012-2688-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-012-2688-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-012-2688-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T13:28:09Z","timestamp":1643462889000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-012-2688-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,28]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1007\/s00134-012-2688-8","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,28]]}}}